National Cancer Institute chief tapped as acting FDA Commissioner

National Cancer Institute chief tapped as acting FDA Commissioner
In the wake of FDA Commissioner Scott Gottlieb’s abrupt resignation, Secretary of Health and Human Services Alex M. Azar III announced that Dr. Ned Sharpless will serve as interim commissioner of the Food and Drug Administration.
Since October 2017, Dr. Sharpless served as director of the National Cancer Institute and, before that, worked as a researcher and hematologist-oncologist at the University of North Carolina. He is also a co-founder of G1 Therapeutics, a biotech firm focused on cancer treatment therapies that went public in May of 2017.
Dr. Sharpless is a temporary appointment, with Secretary Azar saying that the search is on for a permanent candidate for the position, according to the NYT.

(1/3) Change is good, but bittersweet. It is difficult for me to say goodbye to @theNCI family as I head to @FDA to serve as acting commissioner. Rest assured that our shared goals for patients and the public’s health will translate into my new duties.
— Dr. Ned Sharpless (@NCIDirector) March 12, 2019
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Май 2019    »